Stay updated on Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe website footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.6%

- Check32 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check39 days agoChange DetectedThe site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.7.0 is added to the history and the earlier revision v3.6.6 is removed from the history, reflecting an update to the study record's versioning.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history now shows a new version, v3.6.6, replacing the previous v3.6.5. This represents a minor update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page.